Columbia Trust’s AbbVie ABBV Stock Holding History

Columbia Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$292K	Buy	+1,886	New	+$275K	0.13%	115
2023 Q1	–	Sell	-3,485	Closed	-$563K	–	128
2022 Q4	$563K	Sell	3,485 -702	-17%	-$108K	0.31%	86
2022 Q3	$562K	Sell	4,187 -710	-14%	-$102K	0.32%	79
2022 Q2	$750K	Hold	4,897	–	–	0.4%	69
2022 Q1	$795K	Buy	+4,897	New	+$711K	0.37%	75
2021 Q3	–	Sell	-1,902	Closed	-$214K	–	140
2021 Q2	$214K	Buy	1,902 +13	+0.7%	+$1.46K	0.12%	135
2021 Q1	$203K	Hold	1,889	–	–	0.13%	135
2020 Q4	$201K	Buy	+1,889	New	+$182K	0.14%	134
2020 Q2	–	Sell	-3,954	Closed	-$300K	–	128
2020 Q1	$300K	Buy	+3,954	New	+$337K	0.33%	93

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Columbia Trust's ABBV Position: Q4 2023 in Review

Columbia Trust opened a new position in AbbVie (ABBV) in Q4 2023: 1,886 shares worth $292K. The stake represents 0.13% of the portfolio and ranks #115 among its holdings. This is a return to the name: Columbia Trust previously reported a position in ABBV as recently as Q4 2022.

Columbia Trust first reported a position in ABBV in Q1 2020 and has held it in 9 quarters since. The position peaked at $795K in Q1 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Columbia Trust held 1,886 shares of AbbVie worth $292K as of Q4 2023.
AbbVie was a new Columbia Trust position in Q4 2023.
AbbVie made up 0.13% of Columbia Trust's portfolio in Q4 2023, its #115 holding.
Columbia Trust first reported a position in AbbVie in Q1 2020 and has held it in 9 quarters since.
Columbia Trust's AbbVie position peaked at $795K in Q1 2022.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.